Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal Cancer

Name: Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal Cancer
Published: 2020
License: Public Domain

Shanghai Zhongshan Hospital · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

esophageal-squamous-cell-carcinoma gastric-cancer nivolumab

gastric adenocarcinoma, esophageal squamous cell carcinoma, gastric cancer, esophageal cancer, anlotinib hydrochloride, nivolumab, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal Cancer

Related documents